Manuel Narvaez Peláez cursed Medicine and surgery with the best academic record of his promotion. Our team has contributed to the GPCR receptor-receptor interactions field focus in CNS diseases, such as depression, Parkinson, addiction drugs and Alzheimer. As professor, he is performing an independent and emergent line of research, aim to understand the molecular mechanisms and potential relevance of Y1R heterocomplexes interactions in depression and Alzheimer disease, in line with my pioneering work in this field. The research results have been published successively in congresses of international and national relevance. In addition, innovative articles have been published, including in the first quartile of impact index in its category and with quality indices, including high cite numbers. I belong to the CTS-156 of the Junta de Andalucía and the Malaga Biomedical Research Institute (IBIMA). I have reviewed international research projects from CONACYT, Mexico and recently as evaluator for the Call 'Marie Skłodowska-Curie Actions Doctoral Networks' (HE-MSCA-DN-2021).